We actively evaluate partnership opportunities to further develop our pipeline assets, and to create novel therapies combining Redbiotec’s bacterial platforms with a partner’s therapeutic cargo to serve unmet patient needs.

Please contact us for further discussion.

Select industry & academic partners

  • GSK
  • Merck Sharp & Dohme
  • Pfizer
  • Roche
  • Valneva
  • BIA Separations
  • GE Healthcare
  • Merck Millipore
  • PALL
  • TeselaGen
  • ETH Zürich
  • German Cancer Research Center
  • University College Cork
  • University of Zürich

And further undisclosed list of collaborators.